Syed Haroon Khalid| Pharmaceutical Technology | Best Researcher Award

Dr.Syed Haroon Khalid|Pharmaceutical Technology | Best Researcher Award

Dr. Syed Haroon Khalid, Universiti Teknologi Mara (UiTM, Malaysia.

Dr. Syed Haroon Khalid is a distinguished academic at Universiti Teknologi Mara (UiTM) in Malaysia. With a strong background in his field, he has contributed significantly to research and education, focusing on areas pertinent to technology and innovation. Dr. Khalid is dedicated to fostering student engagement and promoting interdisciplinary collaboration, making him a valued member of the academic community at UiTM. His work often bridges theoretical concepts with practical applications, enhancing both learning and industry relevance.

Summary:

Dr. Khalid is a distinguished academic at Universiti Teknologi Mara (UiTM), where he combines theoretical knowledge with practical application. His research interests in pharmaceutical dosage form design and drug delivery systems underline his innovative approach. With his extensive teaching experience and commitment to student development, he effectively bridges the gap between academia and industry.

Professional Profiles:

Google Scholar

šŸŽ“ Education :

Dr. Syed Haroon Khalid holds a PhD in Pharmaceutical Technology from Universiti Sains Malaysia (2015), where he researched curcumin formulations for enhanced antibacterial properties. He also earned an M.Phil in Pharmaceutics from Bahauddin Zakariya University, Pakistan (2006), and a Bachelor of Pharmacy from the same institution (2003).

šŸ¢Ā Experience:

With over 18 years of multidisciplinary experience, Dr. Khalid currently serves as a Senior Lecturer at Universiti Teknologi Mara (UiTM), Malaysia. His previous roles include Assistant Professor and Lecturer at Government College University, Faisalabad, Pakistan, and Quality Assurance Pharmacist at Highnoon Laboratories, Pakistan.

šŸ› ļøSkills:

Dr. Khalid possesses strong communication and interpersonal skills, enabling him to collaborate effectively with diverse teams. He is adaptable, having successfully integrated into international environments, and is proficient in both independent and team-based research settings. His technical expertise includes formulation development, analytical methods, and laboratory management.

Research Focus :

Dr. Khalid specializes in pharmaceutical dosage form design and development, with interests in topical drug delivery, micro/nano emulsions, and solid dispersions. His research has led to significant contributions, as evidenced by a total of 1,680 citations and an H-index of 21.

šŸ”¬Awards:

Dr. Khalid’s contributions have been recognized with various awards, including his role as an academic board member and advisor to the Punjab Public Service Commission. He has also been an active reviewer for numerous prestigious journals.-

Conclusion:

Given Dr. Syed Haroon Khalidā€™s extensive contributions to pharmaceutical technology and education, he is a strong candidate for the Best Researcher Award. His accomplishments reflect a dedication to excellence in research, teaching, and community engagement, positioning him as an influential leader in his field. The recognition of his work through this award would not only honor his achievements but also inspire further advancements in pharmaceutical sciences.

Publications :

  • Identification of phases of various oil, surfactant/co-surfactants and water system by ternary phase diagram
    Authors: HK Syed, KK Peh
    Citations: 139
    Year: 2014

 

  • Stability indicating HPLCā€“UV method for detection of curcumin in Curcuma longa extract and emulsion formulation
    Authors: HK Syed, KB Liew, GOK Loh, KK Peh
    Citations: 135
    Year: 2015

 

  • Designing of biocompatible and biodegradable chitosan-based crosslinked hydrogel for in vitro release of encapsulated povidone-iodine: A clinical translation
    Authors: N Gull, SM Khan, S Khalid, S Zia, A Islam, A Sabir, M Sultan, F Hussain, …
    Citations: 113
    Year: 2020

 

  • Effect of degree of cross-linking on swelling and drug release behaviour of poly (methyl methacrylate-co-itaconic acid) [P (MMA/IA)] hydrogels for site-specific drug delivery
    Authors: SH Khalid, MI Qadir, A Massud, M Ali, MH Rasool
    Citations: 90
    Year: 2009

 

  • Water uptake and drug release behaviour of methyl methacrylate-co-itaconic acid [P (MMA/IA)] hydrogels cross-linked with methylene bis-acrylamide
    Authors: A Hussain, SH Khalid, MI Qadir, A Massud, M Ali, IU Khan, M Saleem, …
    Citations: 87
    Year: 2011

 

  • In vitro and in vivo evaluation of gellan gum hydrogel films: Assessing the co-impact of therapeutic oils and ofloxacin on wound healing
    Authors: H Mahmood, IU Khan, M Asif, RU Khan, S Asghar, I Khalid, SH Khalid, …
    Citations: 80
    Year: 2021

 

  • Nanoemulgel, an innovative carrier for diflunisal topical delivery with profound anti-inflammatory effect: In vitro and in vivo evaluation
    Authors: M Bashir, J Ahmad, M Asif, SUD Khan, M Irfan, A Y Ibrahim, S Asghar, …
    Citations: 49
    Year: 2021

 

  • Facile synthesis of mesoporous silica nanoparticles using modified sol-gel method: Optimization and in vitro cytotoxicity studies
    Authors: Y Mehmood, IU Khan, Y Shahzad, SH Khalid, S Asghar, M Irfan, M Asif, …
    Citations: 48
    Year: 2019

 

  • Co-delivery strategies to overcome multidrug resistance in ovarian cancer
    Authors: YS Ikram Ullah Khan, Rizwan Ullah Khan, Hira Asif, Alamgeer, Syed Haroon Khalid, …
    Citations: 48
    Year: 2017

 

  • Amino-decorated mesoporous silica nanoparticles for controlled sofosbuvir delivery
    Authors: Y Mehmood, IU Khan, Y Shahzad, RU Khan, SH Khalid, AM Yousaf, …
    Citations: 42
    Year: 2020

 

  • In vitro and toxicological assessment of dexamethasone sodium phosphate loaded pH sensitive Pectin-g-poly (AA)/PVP semi interpenetrating network
    Authors: N Ajaz, IU Khan, I Khalid, RU Khan, HA Khan, S Asghar, SH Khalid, …
    Citations: 40
    Year: 2020

 

  • In-vitro and in-vivo evaluation of velpatasvir-loaded mesoporous silica scaffolds. A prospective carrier for drug bioavailability enhancement
    Authors: Y Mehmood, IU Khan, Y Shahzad, RU Khan, MS Iqbal, HA Khan, I Khalid, …
    Citations: 35
    Year: 2020

 

  • Increased aqueous solubility and proapoptotic activity of potassium koetjapate against human colorectal cancer cells
    Authors: SF Jafari, MB Khadeer Ahamed, MA Iqbal, FSR Al Suede, SH Khalid, …
    Citations: 33
    Year: 2014

 

  • Glimepiride-loaded nanoemulgel; development, in vitro characterization, ex vivo permeation and in vivo antidiabetic evaluation
    Authors: FA Razzaq, M Asif, S Asghar, MS Iqbal, IU Khan, SUD Khan, M Irfan, …
    Citations: 29
    Year: 2021

 

  • Preparation and in vitro evaluation of Chondroitin sulfate and carbopol based mucoadhesive controlled release polymeric composites of Loxoprofen using factorial design
    Authors: A Ali, I Khalid, MU Minhas, K Barkat, IU Khan, HK Syed, A Umar
    Citations: 28
    Year: 2019

 

  • Synthesis, characterization and antibacterial activity of a curcuminā€“silver (I) complex
    Authors: HK Syed, MA Iqbal, RA Haque, KK Peh
    Citations: 27
    Year: 2015

 

  • Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters
    Authors: HT Faran SA, Asghar S, Khalid SH, Khan IU, Asif M, Khalid I, Gohar UF
    Citations: 23
    Year: 2019

 

  • Managing hot flushes in menopausal women: a review
    Authors: TH Mallhi, YH Khan, AH Khan, Q Mahmood, SH Khalid, M Saleem
    Citations: 22
    Year: 2018

 

  • Design and evaluation of sodium alginate-based hydrogel dressings containing Betula utilis extract for cutaneous wound healing
    Authors: B Ishfaq, IU Khan, SH Khalid, S Asghar
    Citations: 21
    Year: 2023

 

  • A review and revisit of nanoparticles for antimicrobial drug delivery
    Authors: KB Liew, AK Janakiraman, R Sundarapandian, SH Khalid, FA Razzaq, …
    Citations: 21
    Year: 2022

Bamidele Omotara| analyst | Excellence in Research

Mr.Bamidele Omotara| analyst | Excellence in Research

Mr, Bamidele Omotara,university of new haven, United States.

Mr. Bamidele Omotara is a scholar at the University of New Haven, United States, where he focuses on [insert relevant area of expertise]. With a strong academic background and professional experience, Mr. Omotara has made significant contributions to his field. He is known for his dedication to [specific research or project], aiming to advance knowledge and practical applications in [area of interest]. Mr. Omotara is committed to fostering innovation and collaboration within his academic community, driving positive change through his work.

Summary:

If Mr. Bamidele Omotara possesses strengths like impactful research, innovation, collaboration, and a strong publication record, he could be a strong contender for the “Excellence in Research” award. However, areas like expanding global collaboration, focusing on the broader impact of his work, and enhancing outreach could further elevate his profile.

Professional Profiles:

Scopus

šŸŽ“ Education :

Master of Science in Chemistry,University of New Haven, West Haven, CT
January 2022 ā€“ December 2023,Bachelor of Science in Chemistry,Ekiti State University, Ado Ekiti, Ekiti, Nigeria,January 2010 ā€“ January 2016

šŸ¢Ā Experience:

Computational Chemist (Voluntary)
Bytewave Technologies Inc.,May 2024 ā€“ Present,In this role, I focus on using simulations to identify binding sites on protein molecules for new drug designs. My responsibilities include creating models of synthesis reactions to evaluate kinetic and thermodynamic effects, exploring physical processes such as energy storage and phase changes, and utilizing virtual screening and molecular dynamics for drug design. I am actively involved in molecular docking and dynamics investigations to aid in the development of novel small molecules.,Quality Control Analyst,Peace Standard Pharmaceutical Industries Limited,April 2019 ā€“ December 2021,As a Quality Control Analyst, I conducted extensive quality testing on raw materials, in-process, and finished products. My key tasks involved the execution of standard qualitative and quantitative analyses, managing laboratory test solutions and reagents, calibrating laboratory instruments, and ensuring compliance with cGMP and regulatory standards. I supported the manufacturing process by executing batch records, conducting microbiological risk assessments, and preparing for regulatory audits. I also played a vital role in ensuring product safety and quality across all stages of production.,Quality Control Personnel,GB Foods,November 2016 ā€“ March 2019,I was responsible for overseeing quality control inspections during the production of tomato paste, ensuring product consistency and regulatory compliance. I performed sensory evaluations and laboratory tests to assess various product attributes and collaborated with production teams to resolve quality issues. My duties also included maintaining accurate records, supporting process improvements, and conducting supplier audits to ensure high-quality raw materials.,Production Officer (Intern)Comfort Coatings Limited,March 2014 ā€“ June 2015,During my internship, I maintained laboratory equipment, supported larger projects, and ensured the proper packaging and production of products. I conducted both qualitative and quantitative analyses to ensure quality assurance of finished products, and I also provided technical support for tight-deadline projects, ensuring timely and efficient production.

šŸ› ļøSkills:

Proficiency in operating advanced laboratory instruments such as Gas Chromatography (GC), High-Performance Liquid Chromatography (HPLC), and UV-VIS Spectrometers.,Strong knowledge of cGMP, FDA guidelines, method development, and validation in the pharmaceutical industry.,Advanced computer skills, including Microsoft Office and Laboratory Information Management Systems (LIMS).,Detailed-oriented approach with experience in analytical procedures and working with small molecules.,Extensive experience in raw material testing and laboratory practices.,Expertise in manufacturing processes and quality assurance, adhering to Good Manufacturing Practices (GMP).

Research Focus :

My research focuses on computational chemistry, specifically in drug design using molecular docking and molecular dynamics. I explore protein-drug interactions and develop models to demonstrate the effects of kinetic and thermodynamic changes in chemical reactions. My interests also extend to the study of physical processes such as energy storage and phase transitions, which have applications in fields such as superconductivity and material science.

šŸ”¬Awards:

  • Certification in cGMP and FDA Guidelines
  • Proficiency in Laboratory Information Management Systems

Conclusion:

If Mr. Omotara demonstrates leadership in his research field, innovative contributions, and the ability to influence both academic and broader audiences, he would be well-suited for the “Research for Excellence in Research” award. Improving areas such as global collaboration, focusing on high-impact publications, and public outreach could make his profile even more competitive for future opportunities.

Publications :

  • Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation
    • Authors: Egejuru, W.A., Aderemi, O.E., Egbemhenghe, A.U., Adebayo, F.M., Omotara, B.S.
    • Journal: Informatics in Medicine Unlocked
    • Year: 2024
    • Volume: 46
    • DOI: 101461
    • Citations: 0

 

  • Computational-based drug design of novel small molecules targeting p53-MDMX interaction
    • Authors: Egbemhenghe, A.U., Aderemi, O.E., Omotara, B.S., Abalum, J.O., Afolayan, O.M.
    • Journal: Journal of Biomolecular Structure and Dynamics
    • Year: 2024
    • Volume: 42(13)
    • Pages: 6678ā€“6687
    • Citations: 2

 

  • Identification of promising small-molecule inhibitors targeting STK17B for cancer therapeutics: molecular docking and molecular dynamics investigations
    • Authors: Akinboade, M.W., Egbemhenghe, A.U., Abdulkareem, T.O., Ojeyemi, T., Otuomagie, O.I.
    • Journal: Journal of Biomolecular Structure and Dynamics
    • Year: 2023
    • Citations: 1